Innovating nerve repair. Improving patient outcomes.

CLEANER. SAFER. BETTER.

ABOUT RENERVE

ReNerve specialises in developing a range of ‘ready to use’ products that are cleaner, safer and better for the repair or replacement of damaged peripheral nerves resulting in better patient outcomes.

ReNerve, a medical device company, founded by a neurosurgeon and Medtech Researchers focusing on customised nerve replacement products for specific nerve replacement procedures. Focusing on the innovation and customisation of nerve repair in nerve surgery.

About ReNerve

RENERVE PRODUCT DEVELOPMENT

product-1

NervAlign™ Nerve Cuff

Transected nerves with medium gap.
Synthetic conduits, grafts or donor tissue.

product-2

NervAlign™ Nerve Graft

For transected long gap.
An off-the-shelf, ready to use nerve structure to replace the most challenging repair.

product-3

NervAlign™ Bionic Nerve

For transected long gap.
An off-the-shelf, ready to use nerve structure to replace the most challenging repair.

THE SCIENCE

ReNerve specialises in developing a range of ‘ready to use’ products that are cleaner, safer and better for the repair or replacement of damaged peripheral nerves resulting in better patient outcomes.

ReNerve, a medical device company, founded by a neurosurgeon and Medtech Researchers focusing on customised nerve replacement products for specific nerve replacement procedures. Focusing on the innovation and customisation of nerve repair in nerve surgery.

PARTNERSHIPS

ReNerve has an active colloborative product development program with a number of strategic partners seeking to innovate nerve repair.

ReNerve’s propriety technologies offer an ideal platform for collaborative programs to innovate and develop new products and solutions for peripheral nerve repair. We would welcome opportunities for further discussions.

RENERVE NEWS

ReNerve’s NervAlign® Nerve Cuff receives FDA market clearance

ReNerve Ltd (ReNerve) today announced that it has received market clearance from the FDA for its NervAlign® Nerve Cuff device. This means that the company can now market and sell the product in the United States. The NervAlign Nerve Cuff is a Class II medical device. “Well done to the team. This is a major […]

ReNerve appoints Emerging Surgical to enter US market

ReNerve Ltd (ReNerve) today announced that it has entered into an agreement with Emerging Surgical in San Diego for the launch, promotion and sales of its NervAlign® Nerve Cuff. ReNerve has filed with the FDA for marketing clearance for its NervAlign® Nerve Cuff and anticipates getting FDA approval in the first half of 2022. Emerging […]

Renerve collaboration

ReNerve collaborates with VivaZome to target spinal cord nerve repair

ReNerve has partnered with VivaZome Therapeutics to develop therapeutic solutions for spinal cord repair. The collaboration aims to combine ReNerve’s NervAlignTM Nerve Cuff, which is expected to receive marketing approval from the FDA by early 2022, with VivaZome’s proprietary exosome technology to enhance regrowth in damaged spinal cords.  ReNerve’s NervAlignTM Nerve Cuff is comprised of […]

–– DR DAVID RHODES ––

ReNerve is focused on developing cleaner, safer, better tissue products that aim to provide better outcomes for patients improving their quality of life.